| Medicine (English) | |||||
| Bachelor | TR-NQF-HE: Level 7 | QF-EHEA: Second Cycle | EQF-LLL: Level 7 | ||
| Course Code: | MED200.06 | ||||
| Course Name: | Introduction to Clinical Sciences Committee | ||||
| Course Semester: | Fall | ||||
| Course Credits: |
|
||||
| Language of instruction: | EN | ||||
| Course Requirement: | |||||
| Does the Course Require Work Experience?: | No | ||||
| Type of course: | Necessary | ||||
| Course Level: |
|
||||
| Mode of Delivery: | Face to face | ||||
| Course Coordinator : | Dr.Öğr.Üyesi KADİR DAŞTAN | ||||
| Course Lecturer(s): | Assoc. Prof. Dr. Selçuk Şen, Prof. Dr. Derya Aydın, Prof. Dr. Canan Alatlı, Dr. Öğr. Üyesi Yeşin Üresin, Dr. Öğr. Üyesi Asiye Karakullukçu | ||||
| Course Assistants: |
| Course Objectives: | The aim of this course is to understand the infections/diseases caused by bacteria, viruses, fungi and parasites, to provide basic pathology, microbiology and pharmacology knowledge, to contribute to the learning of general pharmacological properties and clinical use principles of drugs related to systems pharmacology. In addition, to gain research skills for research in medical microbiology, medical pathology and medical pharmacology. |
| Course Content: | MICROBIOLOGY: Giving basic information about medically important bacteria, viruses and parasites and procedures for recognition in laboratories PATHOLOGY: To convey the pathogenesis of diseases, macroscopic and microscopic appearance of lesions, the relationship between morphological findings and prognostic parameters of diseases, morphological findings related to staging and morphological and genetic findings that guide treatment and to gain knowledge about sending the right material PHARMACOLOGY: General definitions and concepts in pharmacology, general pharmacokinetic and pharmacodynamic information about drugs, routes of drug administration, adverse effects, placebo, drug interactions and new drug development stages |
|
The students who have succeeded in this course;
1) Recognition of medically important bacteria, viruses, fungi and parasites Learning the pathogenesis of diseases associated with infectious agents Gaining general pharmacology knowledge 2) Recognition of infectious agents that cause epidemics and pandemics 3) Knowledge of immune responses and function in defense against infections 4) Recognition and activation mechanisms of the immune system 5) Immunopathologies 6) Knowing the importance of vaccines and public health 7) Learning the causes and consequences of pandemic Identification of virologic, immunologic and clinical aspects of the pandemic Learning molecular diagnostics in infections |
| Week | Subject | Related Preparation |
| 1) | Medical Microbiology: 1-Microorganism-human relationships normal body flora 2-Staphylococcus - Streptococcus and Enterococcus genera 4-Enterobacteriaceae - General characteristics - Proteus - Providencia - Morganella and extra-intestinal E. coli 3-Bacillus - Corynebacterium and Listeria genera 5-Klebsiella - Enterobacter - Citrobacter - Serratia - Yersinia genera 6-Pseudomonas - Burkholderia - Stenotrophomonas and Acinetobacter genera Medical Pathology 1-Introduction to Pathology 2-Cell development maturation differentiation 3-Causes of cell injury and cell death 4-Necrosis somatic death apoptosis 5-Cellular adaptation and intracellular accumulation 6-Amyloidosis Medical Pharmacology Introduction to Pharmacology Drug development and clinical trials Cyclical research Forms and routes of administration of medicines | PowerPoint/PDF Presentation Files Blackboard Lecture Videos |
| 2) | Medical Microbiology:8-Anaerobic non-spore bacteria 7-Haemophilus - Bordetella and Pasteurella genera 10-Borrelia - Leptospira and Spirillum genera 11-Rickettsia - Orientia and Coxiella genera 12-Candida genus and other yeasts of clinical importance 9-Clostridium genus Medical Pathology 5-Cellular adaptation and intracellular accumulations 6-Amyloidosis 7-Inflammation I-Description - nomenclature - pathogenesis of acute inflammation 8-Inflammation II-Chemical mediators and chronic inflammation Medical Pharmacology: Pharmacokinetics - Absorption of drugs Pharmacokinetics-Distribution of drugs and binding to proteins Pharmacokinetics - biotransformation processes of drugs Pharmacokinetics - Elimination of drugs | PowerPoint/PDF Presentation Files Blackboard Lecture Videos |
| 3) | Medical Microbiology: 9-Clostridium genus 13-Zygomycetes and dematiaceous fungi 14-Malassezia - Hortea - Piedraia - Trichosporon - Microsporum - Trichophyton - Epidermophyton genera 15-Rubella and mumps viruses 16-Measles and chickenpox viruses 17-Herpesviruses (HSV-1 2 - HHV-6 7 8) and adenoviruses 18-Viral hepatitis agents (A and E) 19-Viral hepatitis agents (B (D and C) 20-HIV and other retroviruses 21-Prions and microorganism-prion differences 22-Oncogenic viruses and microorganism-cancer relationship 23-Vaccines 24-Surveillance and control of microorganisms Epidemiology of nosocomial infections Application Medical Pathology 9-Inflammation III-Morphology of inflammation, healing and living disease agents 10-Neoplasia - Definition - terminology - classification - general morphological features of benign and malignant tumors 11-Cancer epidemiology - clinical and pathological staging prognosis 12-Carcinogenesis I-Oncogenes 13-Carcinogenesis II-Carcinogenic agents 14-Tumor biology-Cell kinetics - Propagation and metastasis 15-Edema and shock 16-Thrombus - embolus - infarction 17-Molecular pathology and genetics Application Medical Pharmacology: Mechanisms of action of drugs-Dose-concentration-effect relationships I Mechanisms of action of drugs-Dose-concentration-effect relationships II Receptors / receptor-drug interactions Factors that modify the effects of drugs. Interactions between drugs Pharmacogenetics Pharmacovigilance | PowerPoint/PDF Presentation Files Blackboard Lecture Videos |
| Course Notes / Textbooks: | PowerPoint/PDF Sunum Dosyaları Blackboard Ders Videoları Murray Temel Tıbbi Mikrobiyoloji Lippincott Farmakoloji Robbins Temel Patoloji Bilimsel dergi ve yayınlar |
| References: | PowerPoint/PDF Presentation Files Blackboard Lecture Videos Murray's Basic Medical Microbiology Lippincott Farmakoloji Robbins Basic Pathology Scientific journals and publications |
| No Effect | 1 Lowest | 2 Medium | 3 Highest |
| Program Outcomes | Level of Contribution | |
| 1) | Has the ability to evaluate the source, boundaries, accuracy, reliability, and validity of knowledge and skills related to the health field. | |
| 2) | Integrates knowledge, skills, and attitudes learned from basic, internal, and surgical medical disciplines in the field of health within an ethical framework. | |
| 3) | Carries out the duties of a physician with a fair approach, considering ethical values without discrimination based on language, religion, race, or sexual orientation. | |
| 4) | Manages general health problems related to all stages of life within the scope of primary care medicine. | |
| 5) | Interprets scientific data under evidence-based medical principles, based on the knowledge acquired in the field of health. | |
| 6) | Demonstrates a trustable and rational approach to providing health services, prioritizing patient and employee health, and collaborating with the community. | |
| 7) | Executes health services based on evidence and up-to-date medical information, considering the patient’s conditions and needs. | |
| 8) | Monitors and evaluates current events related to health at the national and global levels. | |
| 9) | Applies the knowledge and skills acquired most appropriately to improve patient health and combat diseases. | |
| 10) | Strives to provide the most current and high-quality health services, learns from mistakes with insight, self-evaluates, and remains open to criticism in pursuit of excellence. | |
| 11) | Provides the best care for patients and their families by acting sensitively to their well-being. | |
| 12) | Behaves under professional standards in a fair, honest, and respectful manner in professional relationships with patients and colleagues. | |
| 13) | Respect patients’ values and privacy rights, adhering to professional confidentiality in the physician-patient relationship. | |
| 14) | Ensures the protection and improvement of health services by conducting education and activities related to individual and community health within a team framework, without forgetting that access to health is a fundamental right. | |
| 15) | Share thoughts on topics related to the field, as well as possible solutions to problems, with colleagues within a team, supported by scientific data. | |
| 16) | Communicates effectively with patients, their families, individuals with special needs, colleagues, other healthcare workers, and institutions. | |
| 17) | As a healthcare provider, take responsibility for self-improvement and maintain competence, prioritizing personal well-being. | |
| 18) | Contributes to the production and development of scientific knowledge based on professional needs. | |
| 19) | Contributes significantly to evidence-based medicine and One Health areas nationally and internationally through scientific research conducted under universal ethical rules. | |
| 20) | Embraces the concept of lifelong learning by making behavioral changes to access up-to-date information in the field. |
| Course | |
| Labs |
| Yazılı Sınav (Açık uçlu sorular, çoktan seçmeli, doğru yanlış, eşleştirme, boşluk doldurma, sıralama) | |
| Uygulama |
| Semester Requirements | Number of Activities | Level of Contribution |
| Committee | 1 | % 60 |
| Final | 1 | % 40 |
| total | % 100 | |
| PERCENTAGE OF SEMESTER WORK | % 60 | |
| PERCENTAGE OF FINAL WORK | % 40 | |
| total | % 100 | |
| Activities | Number of Activities | Aktiviteye Hazırlık | Aktivitede Harçanan Süre | Aktivite Gereksinimi İçin Süre | Workload | ||
| Course Hours | 2 | 60 | 120 | ||||
| Total Workload | 120 | ||||||